Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Autor:	Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad, Muhammad Salman Faisal, Mark Faber, Matthew Gravina, Pamela J. Sung, Steven D. Green, Amanda Przespolewski, James E. Thompson, Elizabeth A. Griffiths, Eunice S. Wang
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Druh dokumentu:	article
ISSN:	2044-5385
DOI:	10.1038/s41408-023-00910-x
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/1dcaca50f6034f58a690244adc3f7e22 Zobrazit plný text záznamu Full text from SpringerLink View record in DOAJ